Florence Geiguer Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud Hospices Civils de Lyon Biography Publications Institution JoVE Articles Florence Geiguer has not added a biography. If you are Florence Geiguer and would like to personalize this page please email our Author Liaison for assistance. Publications Profiling of Circulating Tumor DNA in Plasma of Non-small Cell Lung Cancer Patients, Monitoring of Epidermal Growth Factor Receptor P.T790M Mutated Allelic Fraction Using Beads, Emulsion, Amplification, and Magnetics Companion Assay and Evaluation in Future Application in Mimicking Circulating Tumor Cells Cancer Medicine. Jul, 2019 | Pubmed ID: 31112372 Cross-platform Comparison for the Detection of RAS Mutations in CfDNA (ddPCR Biorad Detection Assay, BEAMing Assay, and NGS Strategy) Oncotarget. Apr, 2018 | Pubmed ID: 29765524 Non-invasive Prediction of Recurrence in Bladder Cancer by Detecting Somatic TERT Promoter Mutations in Urine British Journal of Cancer. Aug, 2017 | Pubmed ID: 28683471 इम्यूनोफ्लोरेसेंस द्वारा गैर-छोटे सेल फेफड़ों के कैंसर रोगियों से अर्द्ध-स्वचालित पीडी-एल 1 विशेषता और परिसंचरण ट्यूमर कोशिकाओं की गणना Jessica Garcia1,2,3, David Barthelemy1,2,3, Florence Geiguer1,2, Julie Ballandier1,2,3, Kathryn W. Li4, Jean-Phillippe Aurel4, Frédérique Le Breton5, Claire Rodriguez-Lafrasse1, Brigitte Manship3, Sébastien Couraud6,7, Léa Payen1,2,3 1Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 2Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute, 3University of Lyon, Claude Bernard University, Cancer Research Center of Lyon, 4Biolidics Limited, 5Institut de Pathologie Multisites des HCL-Site Sud, Hospices Civils de Lyon, 6Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, 7EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, Lyon 1 University JoVE 59873 Cancer Research
इम्यूनोफ्लोरेसेंस द्वारा गैर-छोटे सेल फेफड़ों के कैंसर रोगियों से अर्द्ध-स्वचालित पीडी-एल 1 विशेषता और परिसंचरण ट्यूमर कोशिकाओं की गणना Jessica Garcia1,2,3, David Barthelemy1,2,3, Florence Geiguer1,2, Julie Ballandier1,2,3, Kathryn W. Li4, Jean-Phillippe Aurel4, Frédérique Le Breton5, Claire Rodriguez-Lafrasse1, Brigitte Manship3, Sébastien Couraud6,7, Léa Payen1,2,3 1Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 2Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute, 3University of Lyon, Claude Bernard University, Cancer Research Center of Lyon, 4Biolidics Limited, 5Institut de Pathologie Multisites des HCL-Site Sud, Hospices Civils de Lyon, 6Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, 7EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, Lyon 1 University JoVE 59873 Cancer Research